Policy experts say premiums are likely to go up for several reasons, including increased use of some higher-cost prescription ...

Whistleblower Sarah Behnke's lawsuit leads to $290 million judgment against CVS Caremark for overcharging Medicare on prescription drugs in 2013 and 2014.

Washington D.C.’s Congressional Budget Office (CBO) recently reported that under President Donald Trump’s One Big Beautiful ...

A federal judge in Texas on Tuesday rejected Elevance Health’s challenge of the U.S. government's calculation for the health ...

A cross-sectional study found that while the Inflation Reduction Act capped out-of-pocket drug costs for Medicare Part D beneficiaries at $2,000 starting in 2025, many enrollees may still face higher ...

The Centers for Medicare & Medicaid Services recently announced a new program to test prior authorization in original ...

A district court in Texas has ruled against the Department of Health and Human Services, deciding to vacate several ...

Medicare launched a new program called GUIDE (Guiding an Improved Dementia Experience) to support individuals diagnosed with ...

The federal budget deficits caused by President Donald Trump’s tax and spending law could trigger automatic cuts to Medicare ...

CVS Health (CVS) stock in focus as its pharmacy benefit manager CVS Caremark faces $289.9M in damages and penalties for ...

Medicare could see deep cuts through 2034 under the Statutory Pay-As-You-Go Act of 2010 after the One Big Beautiful Bill Act was passed on July 4, according to an Aug. 15 Congressional Budget Office ...

A JAMA study published Aug. 18 found that plan design changes by Medicare Part D insurers, particularly for Medicare Advantage plans, following passage of the Inflation Reduction Act of 2022 could ...